© Kirk Starratt
Senator Kelvin Ogilvie
The Rx&D Health Research Foundation recently awarded a medal of honour to the Senator Kelvin Ogilvie for his contributions to health sciences and public health.
The medal comes with a $20,000 research grant, and Ogilvie awarded this grant to Acadia to enhance the study of healthcare delivery in rural Nova Scotia.
“It is a unique privilege to be able to direct this research grant to Acadia,” said Ogilvie. “The delivery of healthcare in rural settings is a major challenge but offers great opportunities for innovative approaches to in-home personal healthcare delivery.
Acadia, he said, is ideally situated to look at the challenges and opportunities for change in this area.
“I have great confidence that the Acadia scholarly community can make a real contribution,” he said.
According to Dr. David MacKinnon, dean of research and graduate studies, the funds will be used to support student research on local in-home health care.
“This is a tremendous opportunity for our students, and we are currently consulting with local health authorities to determine how best to engage the student researchers.”
Ogilvie is a leading expert on biotechnology, bioorganic chemistry and genetic engineering. His scientific accomplishments include the development of the 'Gene Machine', an automated process for the manufacture of DNA. He is the inventor of Ganciclovir, a drug used worldwide to fight infections that occur when the immune system is weakened. He was named a Steacie Fellow in 1982, admitted to the Order of Canada in 1991, inducted into the Canadian Science and Engineering Hall of Fame and received the Biomedical Science Ambassador Award in 2012.